Cerebral ischemia, a pathological condition in which brain tissue experiences a shortage or lack of glucose and oxygen, provokes an irreversible neurodegenerative disorder that may lead clinically to a progressive dementia and global cognitive deterioration. Accumulating evidence indicates many biochemical cascades that lead ultimately to ischemia-induced cell death. However, the cellular and molecular aspects of cerebral ischemia are not yet fully understood. Since the pattern of pathophysiological alterations is not the same for all cells in the ischemic brain, a good understanding of the cellular and molecular alterations induced by cerebral ischemia is needed to develop strategies for the treatment of stroke. This review summarizes recent advances concerning the pathophysiological alterations caused by cerebral ischemia, focusing on the modiˆcation of properties of glutamate receptors, which modiˆcation may be linked to the development of cerebral infarction. Furthermore, the eŠects of hepatocyte growth factor on learning dysfunction and cerebral vessel injury after cerebral ischemia are also summarized. Finally, this review describes a possible ameliorative eŠect of the injection of exogenous neural progenitor cells on cerebral ischemia-induced learning and memory dysfunction.
EŠect of mGluR1 antagonist LY367385 on tyrosine phosphorylation of NR2A (A) and NR2B (B) subunits, the amount of PKCg (C), and src activation (D) in the post-synaptic density fraction at 4 h of reperfusion. C: naä ƒve control, V: vehicle-treated ischemic rats, LY: LY367385-treated ischemic rats.  Signiˆcant diŠer-ence from naä ƒve control rats, p＜0.05.
# Signiˆcant diŠerence from vehicle-treated ischemic rats, p＜0.05. 
